BioSpace News Archive

Press Releases

Inventiva announces completion of enrollment in the Phase 3 NATiV3 clinical trial of lanifibranor in patients with MASH and advanced fibrosis

April 2, 2025
·
12 min read
Press Releases

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - April 1, 2025

April 2, 2025
·
2 min read
Press Releases

Helsinn Group submits a new formulation of AKYNZEO® to the European Medicines Agency (EMA)

April 2, 2025
·
2 min read
Press Releases

Greenwich LifeSciences Announces Positive Immune Response Data from FLAMINGO-01 Phase III Clinical Trial

April 2, 2025
·
9 min read
Press Releases

Edgewise Therapeutics Announces Positive Top-Line Results from Phase 2 CIRRUS-HCM Four-Week Trial of EDG-7500 in Hypertrophic Cardiomyopathy (HCM)

April 2, 2025
·
12 min read
Press Releases

Edgewise Therapeutics Announces Pricing of $200 Million Underwritten Offering of Common Stock

April 2, 2025
·
4 min read
Press Releases

Investigators to Present Clinical Trial Results Showing Neflamapimod Slows Clinical Progression in Dementia with Lewy Bodies in Oral Presentation at AD/PD™ 2025

April 2, 2025
·
10 min read
Press Releases

Labcorp Launches First-of-its-Kind Immunoassay to Accelerate Path to Diagnosis of Alzheimer’s Disease

April 2, 2025
·
3 min read
Press Releases

Palleon Pharmaceuticals Announces NMPA IND Clearance to Proceed with Phase 2 Clinical Trial of E-602 (HLX79), a First-In-Class Treatment for Autoimmune Diseases

April 2, 2025
·
3 min read
Press Releases

Atsena Therapeutics Announces Oversubscribed $150 Million Series C Financing to Further Advance Ocular Gene Therapy Programs

April 2, 2025
·
3 min read